Bellevue Group Ag Exscientia PLC Transaction History
Bellevue Group Ag
- $6.38 Billion
- Q1 2024
A detailed history of Bellevue Group Ag transactions in Exscientia PLC stock. As of the latest transaction made, Bellevue Group Ag holds 2,644 shares of EXAI stock, worth $14,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,644
Previous 1,765
49.8%
Holding current value
$14,198
Previous $11,000
36.36%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EXAI
# of Institutions
85Shares Held
38.6MCall Options Held
99.7KPut Options Held
191K-
Sb Global Advisers LTD London, X05.68MShares$30.5 Million3.51% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M05.68MShares$30.5 Million0.17% of portfolio
-
Laurion Capital Management LP New York, NY5.41MShares$29 Million0.27% of portfolio
-
Baillie Gifford & CO4.57MShares$24.6 Million0.02% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C33.95MShares$21.2 Million0.93% of portfolio
About Exscientia plc
- Ticker EXAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,461,000
- Market Cap $658M
- Description
- Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...